Journal of Clinical Psychopharmacology

  • Home
  • Journal of Clinical Psychopharmacology

Journal of Clinical Psychopharmacology Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Journal of Clinical Psychopharmacology, Media/News Company, .

Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in

psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.

A presidential executive order early this year directed federal departments and agencies to address the issue of chronic...
28/10/2025

A presidential executive order early this year directed federal departments and agencies to address the issue of chronic disease in the United States, including “the prevalence of and threat posed by the prescription of selective serotonin reuptake inhibitors,” with a particular focus on youth. Our latest editorial and podcast revisit the evidence: SSRIs remain safe, effective, and essential for many youth with anxiety, depression, and OCD. The authors, Drs. Jeffrey Strawn and John Walkup, caution that the framing of the issue in the executive order risks reinforcing stigma and diminishing trust in evidence-based pediatric mental health care.
🎧 Listen to the podcast: https://jcpjournal.libsyn.com/fact-versus-fear-antidepressants-in-children-and-adolescents
📰 Read the guest editorial: https://journals.lww.com/psychopharmacology/pages/articleviewer.aspx?year=2025&issue=09000&article=00001&type=Fulltext

What is olfactory reference disorder, and how should it be treated? In our latest Ask the Experts section, Dr. Katharine...
21/10/2025

What is olfactory reference disorder, and how should it be treated? In our latest Ask the Experts section, Dr. Katharine Phillips of Weill Cornell Medicine discusses this underrecognized condition, defined by the persistent false belief of emitting a foul body odor. Often misdiagnosed as OCD or psychosis, ORD can cause severe distress and social isolation.
🔗Read more in our current issue: https://journals.lww.com/psychopharmacology/fulltext/2025/09000/question__what_is_olfactory_reference_disorder,.32.aspx

The Journal of Clinical Psychopharmacology is building a presence on Bluesky, and we’d love for our Facebook community t...
17/10/2025

The Journal of Clinical Psychopharmacology is building a presence on Bluesky, and we’d love for our Facebook community to be part of it.

Follow us on Bluesky for early updates, featured research, and insight into psychopharmacology trends.
📲 @ psychopharm.bsky.social

A newly published comprehensive systematic review in the Journal of Clinical Psychopharmacology analyzes all FDA-approve...
17/10/2025

A newly published comprehensive systematic review in the Journal of Clinical Psychopharmacology analyzes all FDA-approved psychiatric medications for sleep-wake disorders from 2008 to 2024. The review details mechanisms of action, indications, efficacy, dosing, and adverse effects, offering a valuable resource to support evidence-based decision-making in clinical practice.

🔗 https://journals.lww.com/psychopharmacology/fulltext/2025/09000/sleep_wake_disorders__systematic_review_of.12.aspx

Pathologic laughter is a rare but socially disabling neuropsychiatric condition often associated with neurological disor...
15/10/2025

Pathologic laughter is a rare but socially disabling neuropsychiatric condition often associated with neurological disorders and treated with SSRIs. However, in a new JCP case report, pathologic laughter paradoxically emerged in a patient treated with sertraline for major depressive disorder, despite no underlying neurological findings. Read more in our current issue: https://journals.lww.com/psychopharmacology/fulltext/2025/09000/sertraline_associated_pathologic_laughter_in_a.16.aspx

We are pleased to announce an exciting opportunity for early-career researchers: Journal of Clinical Psychopharmacology ...
14/10/2025

We are pleased to announce an exciting opportunity for early-career researchers: Journal of Clinical Psychopharmacology is now accepting applications for its inaugural Editorial Fellowship Program. This two-year, paid fellowship offers hands-on experience in academic publishing and psychiatric research. Learn more below and apply today!

Centanafadine is a potential first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor currently in deve...
10/10/2025

Centanafadine is a potential first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor currently in development for the treatment of ADHD in adults. In a new 52-week trial, centanafadine sustained release was well tolerated and showed sustained improvement in ADHD symptoms in adults. With a favorable safety profile and no signs of abuse or withdrawal, it offers a promising nonstimulant treatment option.
🔗 Read more in our current issue: https://journals.lww.com/psychopharmacology/fulltext/2025/09000/52_week_open_label_safety_and_tolerability_study.6.aspx

Not all low moods are depression. In our latest editorial and podcast, the authors explore how states like demoralizatio...
03/10/2025

Not all low moods are depression. In our latest editorial and podcast, the authors explore how states like demoralization and dispiritedness differ from MDD, and why recognizing these distinctions matters. Better understanding can lead to more accurate diagnoses, fewer unnecessary prescriptions, and improved outcomes.
🎧 Podcast: https://jcpjournal.libsyn.com/variability-in-response-to-antidepressants
📰 Editorial: https://journals.lww.com/psychopharmacology/fulltext/2025/09000/_i_am_depressed___the_many_meanings_that_may.2.aspx

Address


Website

Alerts

Be the first to know and let us send you an email when Journal of Clinical Psychopharmacology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your business to be the top-listed Media Company?

Share